Clinical trialNCT01801423CompletedInterventional

Sickle Cell Disease - Stroke Prevention in Nigeria Trial

SponsorVanderbilt University Medical CenterEnrollment29Sickle Cell AnemiaSickle Cell DiseaseStroke

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Lori Jordan, MD, PhD
Vanderbilt University
Principal Investigator
clinicaltrials.gov ↗
Michael R. DeBaun, MD, MPH
Vanderbilt University
Principal Investigator
clinicaltrials.gov ↗
Muktar Aliyu, MBBS, MPH, DrPH
Vanderbilt University
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Nigeria

Aminu Kano Teaching Hospital
Kano, Nigeria

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 24 Apr 2013
Primary completion: 31 Jan 2019
Completion: 31 Jan 2019
Last update posted: 3 Aug 2020
Registered enrollment: 29
Registry id: NCT01801423

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.